In vitro expansion of Vγ9Vδ2 T cells for immunotherapy

Christian Peters1, Léonce Kouakanou2, Hans-Heinrich Oberg1

  • 1Institute of Immunology, University Hospital Schleswig-Holstein and Christian-Albrechts University Kiel, Kiel, Germany.

Methods in Enzymology
|January 18, 2020
PubMed

Vγ9Vδ2 T cells can exhibit potent anti-tumor activity and have gained much attention as an interesting tool for cancer immunotherapy by adoptive cell transfer. In this chapter, we explain the different approaches for the in vitro expansion of Vγ9Vδ2 T cells for their subsequent adoptive transfer and present a detailed protocol for the successful in vitro expansion at the laboratory scale. Finally, we discuss strategies for optimization and parameters necessary for the adaption to a clinical scale protocol.

Related Concept Videos